New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 17, 2012
07:45 EDTVIVOMeridian Bioscience price target raised to $24 from $22 at RW Baird
Baird raised its price target on Meridian Bioscience following meeting with management. The firm believes investors sentiment is low but feels comfortable with guidance and management strategy for growth. Shares are Outperform rated.
News For VIVO From The Last 14 Days
Check below for free stories on VIVO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 19, 2014
21:01 EDTVIVOMeridian Bioscience could return 20%, Barron's says
Meridian Bioscience's downside looks limited and the stock could return 20%, Barron's contends in its "The Trader" column. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use